<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01451684</url>
  </required_header>
  <id_info>
    <org_study_id>TD003</org_study_id>
    <nct_id>NCT01451684</nct_id>
  </id_info>
  <brief_title>Development of a Non-invasive Prenatal Test</brief_title>
  <official_title>Development of a Non-invasive Prenatal Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cindy Cisneros</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Roche Sequencing Solutions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to aid in the development of a non-invasive prenatal test that
      may be used to aid in detection of fetal aneuploidy. Pregnant women will be recruited and
      asked to provide a blood sample to be used for general test development purposes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood samples and information collected for the study will be used for test development and
      quality control purposes. No test results will be communicated back to study subjects or
      their health care providers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of chromosomal abnormality</measure>
    <time_frame>At time of enrollment</time_frame>
  </primary_outcome>
  <enrollment type="Actual">15000</enrollment>
  <condition>Pregnancy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include women who have a healthy pregnancy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has singleton or twin pregnancy confirmed via evaluation by a healthcare
             provider

          -  Subject is able to provide informed consent

          -  Subject is â‰¥ 18 years of age

          -  Subject is at least 10 weeks gestation for general enrollment

          -  Subject has no known risk factors for chromosomal abnormalities of the fetus

          -  Subject has no suspected or confirmed fetal abnormalities

        Exclusion Criteria:

          -  Subject is pregnant with more than two fetuses

          -  Subject is unwilling to undergo a blood draw
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tracy Roberts</last_name>
    <role>Study Director</role>
    <affiliation>Ariosa Diagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ariosa Diagnostics</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 10, 2011</study_first_submitted>
  <study_first_submitted_qc>October 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <last_update_submitted>April 28, 2020</last_update_submitted>
  <last_update_submitted_qc>April 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Roche Sequencing Solutions</investigator_affiliation>
    <investigator_full_name>Cindy Cisneros</investigator_full_name>
    <investigator_title>CRA</investigator_title>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>fetus</keyword>
  <keyword>euploid</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

